SPIA
ELTX icon

Steward Partners Investment Advisory’s Elicio Therapeutics ELTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.6K Buy
2,023
+469
+30% +$4.53K ﹤0.01% 3194
2025
Q4 		$12.4K Hold
1,554
– – ﹤0.01% 3354
2025
Q3 		$17K Hold
1,554
– – ﹤0.01% 3161
2025
Q2 		$12K Hold
1,554
– – ﹤0.01% 3130
2025
Q1 		$9.57K Hold
1,554
– – ﹤0.01% 3118
2024
Q4 		$7.92K Hold
1,554
– – ﹤0.01% 3193
2024
Q3 		$7.82K Hold
1,554
– – ﹤0.01% 3044
2024
Q2 		$6.39K Hold
1,554
– – ﹤0.01% 2971
2024
Q1 		$11.8K Hold
1,554
– – ﹤0.01% 2748
2023
Q4 		$13K Hold
1,554
– – ﹤0.01% 2599
2023
Q3 		$13.1K Hold
1,554
– – ﹤0.01% 2481
2023
Q2 		$14.8K Sell
1,554
-2
-0.1% -$18 ﹤0.01% 2430
2023
Q1 		$9.02K Hold
1,556
– – ﹤0.01% 2577
2022
Q4 		$12.6K Hold
1,556
– – ﹤0.01% 2457
2022
Q3 		$14K Hold
1,556
– – ﹤0.01% 2380
2022
Q2 		$18K Hold
1,556
– – ﹤0.01% 2270
2022
Q1 		$33K Hold
1,556
– – ﹤0.01% 2123
2021
Q4 		$45K Hold
1,556
– – ﹤0.01% 1969
2021
Q3 		$152K Buy
+1,556
New +$168K ﹤0.01% 1382

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steward Partners Investment Advisory's ELTX Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Elicio Therapeutics (ELTX) stake by 30% in Q1 2026, buying an estimated $4.53K and bringing the position to 2,023 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Steward Partners Investment Advisory first reported a position in ELTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $152K in Q3 2021. 47 funds tracked by Wall St. Rank hold ELTX as of Q1 2026.

  • Steward Partners Investment Advisory held 2,023 shares of Elicio Therapeutics worth $21.6K as of Q1 2026.
  • Steward Partners Investment Advisory bought 469 Elicio Therapeutics shares in Q1 2026, an estimated $4.53K.
  • Elicio Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3194 holding.
  • Steward Partners Investment Advisory first reported a position in Elicio Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Steward Partners Investment Advisory's Elicio Therapeutics position peaked at $152K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.